Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125282191 | 12528219 | 1 | I | 20110801 | 20121106 | 20160705 | 20160705 | EXP | GB-PFIZER INC-1485198 | PFIZER | 0.00 | Y | 0.00000 | 20160705 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125282191 | 12528219 | 1 | PS | MITOXANTRONE HCL | MITOXANTRONE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 12 MG, ONCE A DAY ON DAY 1 | 76871 | 12 | MG | SOLUTION FOR INJECTION | |||||||
| 125282191 | 12528219 | 2 | SS | FLUDARABINE PHOSPHATE. | FLUDARABINE PHOSPHATE | 1 | Oral | 50 MG, ONCE DAILY ON DAY 1 AND 5 | 77790 | 50 | MG | POWDER FOR INJECTION | |||||||
| 125282191 | 12528219 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Oral | 300 MG, ONCE DAILY ON DAY 1 AND 5 | 0 | 300 | MG | ||||||||
| 125282191 | 12528219 | 4 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 980 MG, ONCE DAILY ON DAY 1 | 0 | 980 | MG | ||||||||
| 125282191 | 12528219 | 5 | C | ACYCLOVIR /00587301/ | ACYCLOVIR | 1 | UNK | 0 | |||||||||||
| 125282191 | 12528219 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125282191 | 12528219 | 1 | Chronic lymphocytic leukaemia |
| 125282191 | 12528219 | 2 | Chronic lymphocytic leukaemia |
| 125282191 | 12528219 | 3 | Chronic lymphocytic leukaemia |
| 125282191 | 12528219 | 4 | Chronic lymphocytic leukaemia |
| 125282191 | 12528219 | 5 | Product used for unknown indication |
| 125282191 | 12528219 | 6 | Neuralgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125282191 | 12528219 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125282191 | 12528219 | Febrile neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125282191 | 12528219 | 1 | 20110419 | 0 | ||
| 125282191 | 12528219 | 2 | 20110419 | 0 | ||
| 125282191 | 12528219 | 3 | 20110419 | 0 | ||
| 125282191 | 12528219 | 4 | 20110419 | 0 |